My friends, there are a few inescapable truths:
- Pharma does not (often) buy "ideas", "frameworks" or "technologies". They buy revenue streams.
- From a Pharma perspective, buying a small Australian biotech costs - the (insignificant) purchase price, covering the risk of the key principles departing, linking into the research management structure, reputational risk, etc.
Phylogica is a discovery focused biotech with a platform technology. Pharma have them exactly where they want them:
Starved for capital (which is cheap for Pharma)
At their beck and call - Pharma has no problems getting the research initiatives they want for chump change.
Why would Pharma change this situation?
From a PYC holder's perspective:
- The current shareprice heavily discounts due to the uncertainties and does not adequately reflect the value of the framework.
- More money will need to be spent to fully develop the framework. We are a long way from significant drug royalties.
However, if they can reasonably achieve cash flow self-sustainability - this will be a fantastic company to hold.
- Forums
- ASX - By Stock
- PYC
- Ann: Janssen Collaboration Expanded
Ann: Janssen Collaboration Expanded , page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
|
|||||
Last
10.3¢ |
Change
-0.003(2.38%) |
Mkt cap ! $461.9M |
Open | High | Low | Value | Volume |
10.0¢ | 10.5¢ | 9.8¢ | $491.0K | 4.887M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 326759 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 640089 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 326759 | 0.100 |
4 | 125087 | 0.099 |
2 | 333147 | 0.098 |
4 | 180468 | 0.097 |
5 | 260211 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 621051 | 5 |
0.110 | 684810 | 11 |
0.115 | 639393 | 6 |
0.120 | 690557 | 7 |
0.125 | 390197 | 4 |
Last trade - 15.10pm 29/07/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |